Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma. 1978

N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
March 1977, European journal of cancer,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
September 1976, European journal of cancer,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
November 1977, East African medical journal,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
November 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
December 1976, The Journal of endocrinology,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
October 1980, European journal of cancer,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
January 2015, Nature reviews. Neuroscience,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
June 1975, Journal of steroid biochemistry,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
May 1978, The Journal of endocrinology,
N O Theve, and K Carlström, and J A Gustafsson, and S Gustafsson, and B Nordenskjöld, and H Sköldefors, and O Wrange
October 1999, Clinical endocrinology,
Copied contents to your clipboard!